Menu Search
Equities

Agape ATP Corp

ATPC:NAQ

Agape ATP Corp

Actions
Health CareHealth Care Providers
  • Price (USD)1.92
  • Today's Change0.00 / 0.00%
  • Shares traded95.36k
  • 1 Year change-98.53%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Agape ATP Corp's revenues fell -22.92% from 1.86m to 1.43m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 1.69m to a larger loss of 2.10m.
Gross margin64.23%
Net profit margin-176.47%
Operating margin-182.16%
Return on assets-78.78%
Return on equity-123.81%
Return on investment-111.56%
More ▼

Cash flow in USDView more

In 2023, Agape ATP Corp increased its cash reserves by 235.95%, or 3.39m. Cash Flow from Financing totalled 5.40m or 377.20% of revenues. In addition the company used 2.00m for operations while cash used for investing totalled 17.25k.
Cash flow per share-0.6166
Price/Cash flow per share--
Book value per share0.8366
Tangible book value per share0.8328
More ▼

Balance sheet in USDView more

Agape ATP Corp appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio4.72
Quick ratio4.66
Total debt/total equity0.0232
Total debt/total capital0.0225
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.